
ieso is a UK-based company established in 2000 by two psychologists, with a mission to make mental healthcare more effective and accessible. They have treated over 145,000 patients and built the world's largest outcomes-indexed mental health dataset, leveraging AI, machine learning, and deep neural networks to analyze over 815,000 hours of therapy sessions. Their digital products are available anywhere, anytime, and at any stage of a person's mental health journey. ieso aims to transform mental healthcare by unlocking the power of clinical data, developing scalable, personalized digital mental health products and therapeutics, including their 'ieso Therapy Service (UK)' and 'Velora (US)'. They have raised significant funding, including a $53 million Series B in 2021, to further develop their digital therapeutic (DTx) products.

ieso is a UK-based company established in 2000 by two psychologists, with a mission to make mental healthcare more effective and accessible. They have treated over 145,000 patients and built the world's largest outcomes-indexed mental health dataset, leveraging AI, machine learning, and deep neural networks to analyze over 815,000 hours of therapy sessions. Their digital products are available anywhere, anytime, and at any stage of a person's mental health journey. ieso aims to transform mental healthcare by unlocking the power of clinical data, developing scalable, personalized digital mental health products and therapeutics, including their 'ieso Therapy Service (UK)' and 'Velora (US)'. They have raised significant funding, including a $53 million Series B in 2021, to further develop their digital therapeutic (DTx) products.
Founded: 2000 (Cambridge, UK)
Core product: Therapist-delivered online CBT and AI-driven digital therapeutics
Patients treated: Over 145,000
Series B: $53M (Nov 23, 2021) led by Morningside
Improving accessibility and effectiveness of mental healthcare through digital delivery and data-driven therapeutics.
2000
Digital mental health / digital therapeutics
$53,000,000
Series B announced Nov 23, 2021; reported as £39M (~$53M).
“Backed by Morningside, IP Group, Molten Ventures, Ananda Impact Ventures, and Sony Innovation Fund”